首页> 外文会议>International Conference on Chemical Engineering and Advanced Materials >Controlled release characteristics of PLA-Pluronic-PLAV nano-sized Vesicles iv vitro
【24h】

Controlled release characteristics of PLA-Pluronic-PLAV nano-sized Vesicles iv vitro

机译:PLA-pluronic-Plav纳米尺寸囊泡IV体外控制释放特性

获取原文

摘要

In the present study, controlled release characteristics of new nano-sized PLA-Pluronic-PLA block copolymer vesicles comprising of amphiphilic poly(lactic acid) (PLA) and Pluronic block copolymers (PEO-PPO-PEO) have been evaluated as an oral insulin carrier. The mean size of vesicles was 78 nm for PLA-F127-PLA and 165 nm for PLA-P85-PLA copolymer. The mean insulin entrapment efficiency was 59.6% for PLA-P85-PLA and 26.4% for PLA-F127-PLA. The in vitro release characteristics of insulin from vesicles exhibited an initial burst in the range of pH 1.2-7.4 dissolution mediums. The presence of PLA-Pluronic-PLA vesicles improved the stability of insulin in the gastrointestinal fluids than that of the phosphate buffer solution (PBS) of insulin. More importantly, the released insulin from the vesicles maintained their biological activity. The results from this studies demonstrated that biodegradable PLA-Pluronic-PLA can self-assemble with insulin, form insulin-encapsulated vesicles, and is good carrier materials for oral insulin/protein delivery.
机译:在本研究中,通过胰岛素评估了包含两亲硅(乳酸)(PLA)和PLURONIC嵌段共聚物(PEO-PPO-PE)的新纳米尺寸PLPLONIC-PLA嵌段共聚物囊泡的控制释放特性已被评为口服胰岛素载体。对于PLA-F127-PLA和165nm的PLA-P85-PLA共聚物,囊泡的平均尺寸为78nm。 PLA-P85-PLA的平均胰岛素夹紧效率为59.6%,PLA-F127-PLA的26.4%。来自囊泡的胰岛素的体外释放特性在pH 1.2-7.4溶解介质的范围内表现出初始爆发。 PLA-Pluronic-PLA囊泡的存在改善了胃肠流体中胰岛素的稳定性而不是胰岛素的磷酸盐缓冲溶液(PBS)的稳定性。更重要的是,来自囊泡的释放的胰岛素保持了它们的生物活性。本研究结果证明,可生物降解的PLA-Pluronic-PLA可以用胰岛素自组装,形成胰岛素包封的囊泡,是用于口服胰岛素/蛋白质递送的良好载体材料。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号